# Control-IQ Technology 2.0 Adult and Adolescent Feasibility Study

> **NCT05014789** · NA · COMPLETED · sponsor: **Tandem Diabetes Care, Inc.** · enrollment: 33 (actual)

## Conditions studied

- Diabetes Mellitus, Type 1

## Interventions

- **DEVICE:** Control-IQ technology 2.0

## Key facts

- **NCT ID:** NCT05014789
- **Lead sponsor:** Tandem Diabetes Care, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-19
- **Primary completion:** 2021-12-20
- **Final completion:** 2021-12-20
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2022-01-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05014789

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05014789, "Control-IQ Technology 2.0 Adult and Adolescent Feasibility Study". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05014789. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*